New facility will provide end-to-end solution to accelerate cell therapy development and manufacturing WALTHAM, Mass. and SAN FRANCISCO, May 19, 2021 -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and the University of California, San Francisco (UCSF) today announced they have formed a strategic alliance to accelerate the development and manufacturing of cell-based therapies. Under the agreement, Thermo Fisher will […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
The Houston-based developer is asking San Jose to fast-track a makeover of...
ByThe RegistrySeptember 30, 2026North Palisade Partners marked the completion of the Palisade Fremont Innovation Center...
ByThe RegistrySeptember 30, 2026A Blackstart Digital affiliate plans to buy IBM's former 544,000 SQFT Almaden...
ByThe RegistrySeptember 30, 2026Lam Research's 10-acre, single-roof hub will serve its nearby Livermore factory and...
ByThe RegistrySeptember 30, 2026